Physician/Pharmaceutical Relationships

26
Physician/Pharmaceutic al Relationships Are there Ethical Boundaries ? Katie Grimm, MD Women& Children’s Hospital Adolescent Division [email protected]

description

Physician/Pharmaceutical Relationships. Are there Ethical Boundaries ? Katie Grimm, MD Women& Children’s Hospital Adolescent Division [email protected]. Objectives:. A view from the past: The Medical Ethic The view from Organized Medicine Ethical Underpinnings - PowerPoint PPT Presentation

Transcript of Physician/Pharmaceutical Relationships

Page 1: Physician/Pharmaceutical           Relationships

Physician/Pharmaceutical Relationships

Are there Ethical Boundaries ?

Katie Grimm, MDWomen& Children’s HospitalAdolescent [email protected]

Page 2: Physician/Pharmaceutical           Relationships

Objectives:

A view from the past: The Medical EthicThe view from Organized MedicineEthical UnderpinningsToday’s viewpointIs there a resolution?

Page 3: Physician/Pharmaceutical           Relationships

Original Code of Medical EthicsNational Medical Convention of the AMA,1847

“Medical ethics, as a branch of general ethics, must rest on the basis of religion and morality”

“Veracity, so requisite in all the relations of life, is a jewel of inestimable value in medical description and narrative, the lustre of which ought never to be tainted for a moment, by even the breath of suspicion”

Page 4: Physician/Pharmaceutical           Relationships

“We are under the strongest ethical obligations to preserve the character which has been awarded, by the most learned men and best judges of human nature, to the members of the medical profession…” (Code, 1847)

CEJA Report 2001: “building on the Hippocratic tradition, physicians were called upon to hold a sense of ethical obligation that rose above considerations of personal advancement”

Page 5: Physician/Pharmaceutical           Relationships

The AMA : the medical profession’s “prime objective” is to render service to humanity (Beauchamp &Childress)

Physicians urged to be “upright” and “pure in character and ….diligent and conscientious in caring for the sick.”

Virtues have been de-emphasized since the 1847 Code of Ethics

Does emphasis on virtues change depending on the practice patterns at the time?

Page 6: Physician/Pharmaceutical           Relationships

Bringing focus to the problem

Early characterization by the AMA calling the early pharmaceutical companies the “ethical”

drug companies, to distinguish them from unscrupulous patent-medicine peddlers.

The concern is now the embedding of these companies within the relationship between the physician and the patient

Page 7: Physician/Pharmaceutical           Relationships

Far too large a section of the treatment of disease is today controlled by the big manufacturing pharmacists, who

have enslaved us in a plausible pseudo-science. The remedy is obvious-give

our students a first-hand acquaintance with disease and give them a thorough practical knowledge of the great drugs

and we will send out independent,clear-headed,cautious practitioners who will do their own

thinking…….

Sir William Osler, 1909 Can Lancet

Page 8: Physician/Pharmaceutical           Relationships

Is there an ethical basis for decision making?

There is not one ethical theory, nor moral solution to provide a single solution but there are foundations based in ethical philosophy

Principles and rules are not always the determinant of moral character, but rather it is the agent who performs these actions that is important

Rules do not determine compassion, patience and patient responsiveness (Beauchamp and Childress)

“Virtues” are the determinant of the value of a relationship

Page 9: Physician/Pharmaceutical           Relationships

Principles

Autonomy BeneficenceNon-MaleficenceJustice

Page 10: Physician/Pharmaceutical           Relationships

Autonomy

Liberty: Freedom to influence choices and decisions

The primary responsibility of the physician is to serve the patient’s interest

Truth telling by the physician is an integral part of understanding autonomy

Page 11: Physician/Pharmaceutical           Relationships

Beneficence

To do “good”

Conflict of interest :must not participate in activities that are not in a patient’s best interest

Page 12: Physician/Pharmaceutical           Relationships

Non-Malficence

To do no harm, to avoid harm, and to prevent harm

Page 13: Physician/Pharmaceutical           Relationships

Justice

Distributive Justice fairness, what is deserved, entitlement

Broadly refers to “rights and responsibilities”

Page 14: Physician/Pharmaceutical           Relationships

Character more important than rules, and virtuous character can be cultivated over time through role models, educational interactions

An Aristotelian framework that understands that virtuous behavior can be a skill that is learned, cultivated, and rewarded

Professional roles incorporate virtues as a basis for action

Professional virtues are historically ingrained and integrated in medicine

Page 15: Physician/Pharmaceutical           Relationships

Five Focal VirtuesCompassion : active regard for another

person’s welfareDiscernment : “sensitive insight, acute

judgment, and understanding..” (how principles and rules are applied in given contexts)

Trustworthiness : “ a confidence that another will act with the right motives and in accordance with appropriate social norms”

Integrity : fidelityConscientiousness : due diligence

Page 16: Physician/Pharmaceutical           Relationships

“Science cannot stop while ethics catches up”Howard Brody, a medical ethicist, has

characterized this as “moral compromise”What may have started as a casual alliance

has now such complexity and “invisible” bonds that is often difficult to discern the level of embedding

“A Profession is not just a way of making money; it’s a form of public trust…”

Page 17: Physician/Pharmaceutical           Relationships

What is happening today?December, 2007 : White Paper authored by

the Corporate Governance Task Force of the American Health Lawyers Association Vendor-Healthcare Professional Gift Giving, Marketing, and Compliance

“ approximately 90% of the $21 billion marketing budget of the pharmaceutical industry is directed at physicians…”

“rising health care costs have increased scrutiny of these interactions”

Page 18: Physician/Pharmaceutical           Relationships

What about today?January 25, 2006: JAMA “ Health Industry

Practices that create Conflicts of Interest”“ Physicians’ commitment to altruism….now

regularly come up against financial conflicts of interest”

From The Lancet:“ Do those doctors who support this culture for the best of intentions…have the courage to oppose practices that bring the whole of medicine into disrepute?”

Page 19: Physician/Pharmaceutical           Relationships

MD vs. MDeityHow to separate legitimate vs. non-legitimate

endeavors?Minnesota data: Doctors and medical

organizations received more than $42 million from the pharmaceutical industry from 2002-2005

There are variations in these relationships that vary according to state, specialty, and professional activity

No “broad-brush” approach

Page 20: Physician/Pharmaceutical           Relationships

From the Lancet, April 6,2002: “spending on prescription drugs in the USA soar(ed) by a remarkable 17% in 2001…retail spending on prescription drugs was $155 billion in 2001, almost double what it was in 1997”

“How tainted by commercial conflicts has medicine become?”

Page 21: Physician/Pharmaceutical           Relationships

JAMA, 2006

“Conflicts of interest occur when physicians have motives or are in situations for which reasonable observers could conclude that the moral requirements of the physician’s roles are or will be compromised.”

Page 22: Physician/Pharmaceutical           Relationships

“ Grants or support for educational activities that are sponsored and organized by medical professional organizations raise little risk of fraud”

An “explosion” of change in the area of enforcement of policy and procedures that have been written describing professional relationships with vendors and drug companies

Page 23: Physician/Pharmaceutical           Relationships

Is the Virtuous Physician model

Attainable?Is the highly complex world of medicine an

environment that is impossible to carry out the professional commitment?

Codes of Ethics that attempt to clarify the mores of action

Caution with oversimplification,i.e. pursuit of professional norms to protect the professions’ interest

Need for persistent improvement and educationPublic supervision and scrutiny

Page 24: Physician/Pharmaceutical           Relationships

Increasing scrutiny requires vigilance to maintain the ethic that has defined the fiduciary relationship that is the tradition in medicine

Self-regulation to reduce the need for external regulation and legislation

AMA tasks for an organized medical staff :“ develop disclosure and conflict of interest policies for physicians in leadership”

Page 25: Physician/Pharmaceutical           Relationships

Ethics EducationThe Oslerian viewPhysician disclosure and preserving the

fiduciary relationshipDialogue on the issues An evolving role for the bioethicist?The global view“Ethics permeates all that we do in medicine”

: beliefs which guide our actions

Page 26: Physician/Pharmaceutical           Relationships

Thank you !!